Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An announcement from Fuso Pharmaceutical Industries,Ltd. ( (JP:4538) ) is now available.
Fuso Pharmaceutical Industries reported its non-consolidated financial results for the three months ended June 30, 2025, showing a 6% increase in net sales compared to the previous year. However, the company experienced a significant decline in operating and ordinary profits, with decreases of 48.1% and 28.8% respectively, indicating potential challenges in maintaining profitability. The financial forecast for the fiscal year ending March 31, 2026, suggests modest growth in net sales but continued pressure on profits, impacting stakeholders’ expectations.
More about Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries, Ltd. is a company listed on the Tokyo Stock Exchange, primarily involved in the pharmaceutical industry. The company focuses on the development and sale of pharmaceutical products, catering to various healthcare needs.
Average Trading Volume: 17,054
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen19.61B
See more insights into 4538 stock on TipRanks’ Stock Analysis page.